2005
DOI: 10.1016/j.vaccine.2005.01.057
|View full text |Cite
|
Sign up to set email alerts
|

Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
48
0

Year Published

2008
2008
2022
2022

Publication Types

Select...
4
3
2

Relationship

0
9

Authors

Journals

citations
Cited by 64 publications
(51 citation statements)
references
References 8 publications
3
48
0
Order By: Relevance
“…Few tuberculosis studies with macaques (most commonly, vaccine studies) have been able to identify quantitative differences between groups of monkeys (17,27,31). Other studies of macaques with M. tuberculosis infection either have not been able to detect a difference in bacterial burden (18) or did not report differences in bacterial burden between experimental groups (16,22,29). This is surprising, given that most of these studies involved high-dose M. tuberculosis infection and are likely to demonstrate more dramatic differences than our low-dose model of infection.…”
Section: Discussionmentioning
confidence: 99%
“…Few tuberculosis studies with macaques (most commonly, vaccine studies) have been able to identify quantitative differences between groups of monkeys (17,27,31). Other studies of macaques with M. tuberculosis infection either have not been able to detect a difference in bacterial burden (18) or did not report differences in bacterial burden between experimental groups (16,22,29). This is surprising, given that most of these studies involved high-dose M. tuberculosis infection and are likely to demonstrate more dramatic differences than our low-dose model of infection.…”
Section: Discussionmentioning
confidence: 99%
“…A series of subsequent investigations were dedicated to macaque research to assess novel TB vaccines and drugs, as well as to gain an understanding of the pathogenesis of M. tuberculosis infection and reactivation. Figures 2 and 3 abridge the RM (13,(26)(27)(28)(29)(30)(31)(32)(33)(34)(35)(36)(37)(38)(39)(40)(41)(42)(43) and CM (10,15,25,(42)(43)(44)(45)(46)(47)(48)(49)(50)(51)(52)(53)(54)(55)(56)(57)(58)(59) models of experimental M. tuberculosis infection after the Golden Age, from 2001 to 2014.…”
Section: Historical Outlook On Macaque Modelsmentioning
confidence: 99%
“…Between 2005 and 2012, three reported studies using CM models evaluated the efficacy of TB vaccines that had been tested previously with smaller animal models, including guinea pigs and mice (44,45). The first project evaluated the efficacy of the 72f recombinant BCG vaccine and HASP65 plus interleukin-12 (IL-12)/HVJ vaccine (44), which another team of investigators also tested later in Osaka, Japan (45). Both research investigations showed that the recombinant BCG vaccines were more effective than BCG alone.…”
Section: Specific Macaque Models Of Tbmentioning
confidence: 99%
“…Yoko Kita, 1 Masaji Okada, 1, * Toshihiro Nakajima, 2 Noriko Kanamaru, 1 Satomi Hashimoto, 1 Tetsuji Nagasawa,…”
Section: Development Of Therapeutic and Prophylactic Vaccine Against mentioning
confidence: 99%